Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Pennant Group ( (PNTG) ) has provided an announcement.
On November 5, 2025, The Pennant Group announced its third-quarter 2025 financial results, highlighting a 26.8% increase in total revenue to $229 million compared to the previous year. The company reported a GAAP diluted earnings per share of $0.17 and an adjusted earnings per share of $0.30. Notably, the company completed a significant acquisition of 54 operations from UnitedHealth Group and Amedisys on October 1, 2025, marking its largest transaction to date. This expansion into the Southeast is expected to enhance Pennant’s market presence and operational capabilities.
The most recent analyst rating on (PNTG) stock is a Hold with a $27.00 price target. To see the full list of analyst forecasts on Pennant Group stock, see the PNTG Stock Forecast page.
Spark’s Take on PNTG Stock
According to Spark, TipRanks’ AI Analyst, PNTG is a Neutral.
Pennant Group’s strong financial performance and positive earnings call sentiment are key strengths, driving the overall score. However, technical indicators suggest a neutral trend, and valuation concerns due to a high P/E ratio and lack of dividend yield weigh on the score.
To see Spark’s full report on PNTG stock, click here.
More about Pennant Group
The Pennant Group, Inc. operates as a holding company for independent subsidiaries providing healthcare services through home health, hospice agencies, and senior living communities across several states including Arizona, California, and Texas. Each subsidiary operates independently with its own management and assets.
Average Trading Volume: 343,812
Technical Sentiment Signal: Hold
Current Market Cap: $873.7M
Find detailed analytics on PNTG stock on TipRanks’ Stock Analysis page.